Home » FDA Broadens Clearance for Agendia’s MammaPrint
FDA Broadens Clearance for Agendia’s MammaPrint
Agendia, a world leader in molecular cancer diagnostics, announced Thursday that
the US Food and Drug Administration (FDA) cleared its MammaPrint breast cancer recurrence test for all ages.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May